Search research articles
Contact Us
Filters
Showing results (51-60 of 552) with videos related to
Page
of 56
Sort By:
Science (New York, N.Y.)
|
July 28, 2016
Latency reversal and viral clearance to cure HIV-1
David M Margolis, J Victor Garcia, Daria J Hazuda, et al.
European Journal of Immunology
|
October 18, 2002
Leukemia inhibitory factor is a mediator of Escherichia coli lipopolysaccharide-induced acute thymic atrophy
Gregory D Sempowski, Maria E Rhein, Richard M Scearce, et al.
The New England Journal of Medicine
|
May 20, 2011
Acute HIV-1 Infection
Myron S Cohen, George M Shaw, Andrew J McMichael, et al.
Cell Reports
|
October 4, 2018
Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral Latency
Todd Bradley, Guido Ferrari, Barton F Haynes, et al.
Annual Review of Medicine
|
August 24, 2021
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment
Dapeng Li, Gregory D Sempowski, Kevin O Saunders, et al.
Plos Computational Biology
|
January 30, 2008
Coping with viral diversity in HIV vaccine design: a response to Nickle et al
Will Fischer, H X Liao, Barton F Haynes, et al.
Human Antibodies
|
May 25, 2006
Antibody polyspecificity and neutralization of HIV-1: a hypothesis
Barton F Haynes, M Anthony Moody, Laurent Verkoczy, et al.
Nature Reviews. Immunology
|
December 17, 2009
The immune response during acute HIV-1 infection: clues for vaccine development
Andrew J McMichael, Persephone Borrow, Georgia D Tomaras, et al.
Current Opinion in HIV and AIDS
|
September 26, 2023
Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
Barton F Haynes, Kevin Wiehe, S Munir Alam, et al.
Trends in Molecular Medicine
|
November 30, 2010
B cell responses to HIV-1 infection and vaccination: pathways to preventing infection
Barton F Haynes, M Anthony Moody, Hua-Xin Liao, et al.
Page
of 56
Search research articles
Search
Showing results (51-60 of 552) with videos related to
Sort By:
Page
of 56
Science (New York, N.Y.)
|
July 28, 2016
Latency reversal and viral clearance to cure HIV-1
David M Margolis, J Victor Garcia, Daria J Hazuda, et al.
European Journal of Immunology
|
October 18, 2002
Leukemia inhibitory factor is a mediator of Escherichia coli lipopolysaccharide-induced acute thymic atrophy
Gregory D Sempowski, Maria E Rhein, Richard M Scearce, et al.
The New England Journal of Medicine
|
May 20, 2011
Acute HIV-1 Infection
Myron S Cohen, George M Shaw, Andrew J McMichael, et al.
Cell Reports
|
October 4, 2018
Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral Latency
Todd Bradley, Guido Ferrari, Barton F Haynes, et al.
Annual Review of Medicine
|
August 24, 2021
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment
Dapeng Li, Gregory D Sempowski, Kevin O Saunders, et al.
Plos Computational Biology
|
January 30, 2008
Coping with viral diversity in HIV vaccine design: a response to Nickle et al
Will Fischer, H X Liao, Barton F Haynes, et al.
Human Antibodies
|
May 25, 2006
Antibody polyspecificity and neutralization of HIV-1: a hypothesis
Barton F Haynes, M Anthony Moody, Laurent Verkoczy, et al.
Nature Reviews. Immunology
|
December 17, 2009
The immune response during acute HIV-1 infection: clues for vaccine development
Andrew J McMichael, Persephone Borrow, Georgia D Tomaras, et al.
Current Opinion in HIV and AIDS
|
September 26, 2023
Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
Barton F Haynes, Kevin Wiehe, S Munir Alam, et al.
Trends in Molecular Medicine
|
November 30, 2010
B cell responses to HIV-1 infection and vaccination: pathways to preventing infection
Barton F Haynes, M Anthony Moody, Hua-Xin Liao, et al.
Page
of 56